4//SEC Filing
Wise John Drayton 4
Accession 0001628280-24-025895
CIK 0001104506other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:46 PM ET
Size
10.2 KB
Accession
0001628280-24-025895
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-28$12.58/sh+6,250$78,625→ 127,907 total - Sale
Common Stock
2024-05-28$50.00/sh−6,250$312,500→ 121,657 total - Exercise/Conversion
Stock Option (right to buy)
2024-05-28−6,250→ 0 totalExercise: $12.58Exp: 2024-06-02→ Common Stock (6,250 underlying) - Sale
Common Stock
2024-05-28$48.95/sh−1,602$78,418→ 121,657 total
Footnotes (3)
- [F1]Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
- [F2]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F3]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001930805
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:46 PM ET
- Size
- 10.2 KB